Searching PubMed for “Clinical Trial” and checking full-text availability…
for “Clinical Trial” · Showing 81–100 · 954 ms
Feuerman E·Harefuah
Abstract not available
Duckworth R, Waterhouse J P, Britton D E, +4 more·British dental journal
Abstract not available
Thorp R H, Hughes E S·The Medical journal of Australia
Abstract not available
Zürcher H P·Praxis
Abstract not available
Svestka J, Náhunek K, Rodová A·Scripta medica
Abstract not available
The British journal of clinical practice
Abstract not available
Brown C A·Transactions of the ophthalmological societies of the United Kingdom
Abstract not available
Sabri S, Higgins R F, Roberts V C, +3 more·Postgraduate medical journal
Twenty-four patients with Raynaud's phenomenon were treated with griseofulvin and a placebo in a double-blind cross-over clinical trial. The results were assessed subjectively and plotted sequentially. The number of patients able to distinguish the active from the placebo treatment was statistically significant (=0…
Kugimiya T, Yamamura H, Amaha K·Masui. The Japanese journal of anesthesiology
Abstract not available
Pryor J P, Blandy J P, Evans P, +2 more·British journal of urology
64 infertile men with oligozoospermia took part in a double blind cross-over trial. Each patient received matching capsules of a placebo and arginine for periods of 12 weeks. There was no difference in the conception rates of the wives or changes in the quality of the semen during each period of treatment.
Calaghan N, McIlroy M, O'Connor M·Irish journal of medical science
Abstract not available
Adeloye A·The Practitioner
Abstract not available
Hunt J·Nursing mirror
Abstract not available
Alter M, Greenstein J, Camenga D, +1 more·Neuroepidemiology
The design and course of a placebo-controlled alpha-2 interferon trial in MS patients are described. No beneficial effect of the interferon on the course of MS could be shown.
Hagemeijer F·Revue medicale de Liege
Abstract not available
Sladká R, Dostálová J, Haskovcová V, +4 more·Therapia Hungarica (English edition)
Abstract not available
Simmons F, Goldstein H, Boyle J D·Gastroenterology
Abstract not available
van Rossum J, Wintzen A R, Endtz L J, +2 more·Annals of neurology
In a double-blind controlled clinical trial on 51 patients with subarachnoid hemorrhage, tranexamic acid, 4 gm per day for ten consecutive days, did not favorably affect the outcome. Neither mortality nor rebleeding rates were improved after a follow-up of three months.
Forsythe W I, Merrett J D, Redmond A·The British journal of clinical practice
Abstract not available
Pye S D, Wild S R, McDicken W N, +4 more·The British journal of radiology
Abstract not available